{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:46:11Z","timestamp":1793303171233,"version":"4.5.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"9","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,14]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>In leukemogenesis, genotoxic stress in hematopoietic stem and progenitor cells (HSPCs) drives individual context-dependent programs of malignant transformation. In light of the various differentiation stages of HSPCs based on a recently revised definition using CD150\/CD48, our analyses showed that a subpopulation of long-term repopulating HSCs was most susceptible to MLL-ENL\u2013mediated transformation. An analysis of the molecular mechanism identified Bromo-adjacent homology domain and coiled-coil containing 1 (Bahcc1), which encodes a reader molecule of trimethylated histone H3 lysine 27 (H3K27me3), as a candidate gene involved in distinct susceptibility to leukemic transformation. Interestingly, Bahcc1 was previously reported to be highly expressed in acute myeloid leukemia (AML) with an unfavorable prognosis, including some cases of MLL-rearranged AML. We found that MLL-ENL upregulated Bahcc1 through binding to its promoter, and that Bahcc1 was involved in MLL-ENL\u2013mediated immortalization at least partly through repression of H3K27me3-marked Cdkn1c. Analyses using bone marrow transplantation in mice showed that depletion of Bahcc1 suppressed the leukemogenic activity of MLL-ENL. In a public database, high BAHCC1 expression was found to be associated with a poor prognosis in pediatric AML, in which BAHCC1 expression was significantly lower in MLL-AF9-AML than in other MLL-fusion-AML. These findings shed light on the distinct immortalization potential of HSPCs and suggest a novel MLL-fusion-Bahcc1 axis, which may lead to development of molecular targeted therapy against MLL-fusion\u2013mediated leukemia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011320","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T21:14:41Z","timestamp":1709846081000},"page":"2193-2206","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["<i>Bahcc1<\/i> is critical for the aberrant epigenetic program in a mouse model of <i>MLL-ENL\u2013<\/i>mediated leukemia"],"prefix":"10.1182","volume":"8","author":[{"given":"Akihide","family":"Nakamura","sequence":"first","affiliation":[{"name":"1Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan"},{"name":"2Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Masuya","sequence":"additional","affiliation":[{"name":"2Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Shinmei","sequence":"additional","affiliation":[{"name":"1Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-9422","authenticated-orcid":false,"given":"Isao","family":"Tawara","sequence":"additional","affiliation":[{"name":"2Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0037-7049","authenticated-orcid":false,"given":"Tetsuya","family":"Nosaka","sequence":"additional","affiliation":[{"name":"1Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Ono","sequence":"additional","affiliation":[{"name":"1Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"issue":"7","key":"2024051415213821300_bib1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"issue":"suppl 1","key":"2024051415213821300_bib2","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1073\/pnas.2034201100","article-title":"Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?","volume":"100","author":"Passegu\u00e9","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2024051415213821300_bib3","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1089\/ars.2017.7326","article-title":"Hematopoietic stem cells: normal versus malignant","volume":"29","author":"Carroll","year":"2018","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2024051415213821300_bib4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41467-021-21650-1","article-title":"Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics","volume":"12","author":"Velten","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"2024051415213821300_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ccr.2008.03.005","article-title":"Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells","volume":"13","author":"Chen","year":"2008","journal-title":"Cancer Cell"},{"issue":"7488","key":"2024051415213821300_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"issue":"1","key":"2024051415213821300_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ccell.2016.05.011","article-title":"MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome","volume":"30","author":"Stavropoulou","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"2024051415213821300_bib8","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1038\/s41467-019-13666-5","article-title":"MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"2024051415213821300_bib9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood-2012-09-456665","article-title":"Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells","volume":"122","author":"Ono","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2024051415213821300_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","article-title":"SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells","volume":"121","author":"Kiel","year":"2005","journal-title":"Cell"},{"issue":"6","key":"2024051415213821300_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.20091318","article-title":"Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment","volume":"207","author":"Morita","year":"2010","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"2024051415213821300_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1182\/blood-2010-12-322339","article-title":"CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation","volume":"118","author":"Boles","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2024051415213821300_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.stem.2015.05.003","article-title":"Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions","volume":"17","author":"Pietras","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2024051415213821300_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc2765","article-title":"Leukemogenesis: more than mutant genes","volume":"10","author":"Chen","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2024051415213821300_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"issue":"7","key":"2024051415213821300_bib16","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/leu.2014.94","article-title":"Chromatin modifiers and the promise of epigenetic therapy in acute leukemia","volume":"28","author":"Greenblatt","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"2024051415213821300_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jb\/mvv114","article-title":"Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD)","volume":"159","author":"Kitamura","year":"2016","journal-title":"J\u00a0Biochem"},{"issue":"6330","key":"2024051415213821300_bib18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1126\/science.aam7304","article-title":"The cancer epigenome: concepts, challenges, and therapeutic opportunities","volume":"355","author":"Dawson","year":"2017","journal-title":"Science"},{"issue":"8","key":"2024051415213821300_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"2024051415213821300_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"issue":"2","key":"2024051415213821300_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"12","key":"2024051415213821300_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41580-021-00398-y","article-title":"The molecular principles of gene regulation by Polycomb repressive complexes","volume":"22","author":"Blackledge","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"2024051415213821300_bib23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41588-020-00729-3","article-title":"BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis","volume":"52","author":"Fan","year":"2020","journal-title":"Nat Genet"},{"issue":"8","key":"2024051415213821300_bib24","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1093\/nar\/gkab210","article-title":"A\u00a0conserved BAH module within mammalian BAHD1 connects H3K27me3 to Polycomb gene silencing","volume":"49","author":"Fan","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2024051415213821300_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1158\/2159-8290.CD-13-0419","article-title":"NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function","volume":"4","author":"Gough","year":"2014","journal-title":"Cancer Discov"},{"issue":"3","key":"2024051415213821300_bib26","doi-asserted-by":"crossref","first-page":"e0248425","DOI":"10.1371\/journal.pone.0248425","article-title":"Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models","volume":"16","author":"Ono","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"2024051415213821300_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","article-title":"Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics","volume":"31","author":"Kitamura","year":"2003","journal-title":"Exp Hematol"},{"issue":"12","key":"2024051415213821300_bib28","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/leu.2009.177","article-title":"Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation","volume":"23","author":"Ono","year":"2009","journal-title":"Leukemia"},{"issue":"13","key":"2024051415213821300_bib29","doi-asserted-by":"crossref","first-page":"e00585-16","DOI":"10.1128\/MCB.00585-16","article-title":"Eya2, a target activated by Plzf, is critical for PLZF-RARA-induced leukemogenesis","volume":"37","author":"Ono","year":"2017","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2024051415213821300_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI200522725","article-title":"Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis","volume":"115","author":"Ono","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"5973","key":"2024051415213821300_bib31","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"12","key":"2024051415213821300_bib32","doi-asserted-by":"crossref","first-page":"e1009250","DOI":"10.1371\/journal.pgen.1009250","article-title":"MLL1 is required for maintenance of intestinal stem cells","volume":"17","author":"Goveas","year":"2021","journal-title":"PLoS Genet"},{"key":"2024051415213821300_bib33","doi-asserted-by":"crossref","first-page":"e64148","DOI":"10.7554\/eLife.64148","article-title":"HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways","volume":"10","author":"Miyamoto","year":"2021","journal-title":"eLife"},{"issue":"23","key":"2024051415213821300_bib34","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1038\/onc.2016.488","article-title":"MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia","volume":"36","author":"Prange","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"2024051415213821300_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12185-022-03469-8","article-title":"Dual inhibition of EZH1\/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1","volume":"117","author":"Ito","year":"2023","journal-title":"Int J Hematol"},{"issue":"2","key":"2024051415213821300_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3324\/haematol.2010.029660","article-title":"Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia","volume":"96","author":"Balgobind","year":"2011","journal-title":"Haematologica"},{"issue":"7","key":"2024051415213821300_bib37","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/leu.2015.95","article-title":"NFATc1 as a therapeutic target in FLT3-ITD-positive AML","volume":"29","author":"Metzelder","year":"2015","journal-title":"Leukemia"},{"issue":"7074","key":"2024051415213821300_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies","volume":"439","author":"Bild","year":"2006","journal-title":"Nature"},{"issue":"3","key":"2024051415213821300_bib39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/leu.2010.316","article-title":"MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study","volume":"25","author":"Pigazzi","year":"2011","journal-title":"Leukemia"},{"issue":"4","key":"2024051415213821300_bib40","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/HS9.0000000000000051","article-title":"A\u00a0novel inducible mouse model of MLL-ENL-driven mixed-lineage acute leukemia","volume":"2","author":"Stavropoulou","year":"2018","journal-title":"Hemasphere"},{"issue":"4","key":"2024051415213821300_bib41","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.celrep.2014.10.036","article-title":"Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation","volume":"9","author":"Ugale","year":"2014","journal-title":"Cell Rep"},{"issue":"16","key":"2024051415213821300_bib42","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood-2016-10-691428","article-title":"Mouse models of MLL leukemia: recapitulating the human disease","volume":"129","author":"Milne","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2024051415213821300_bib43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/ijms20020453","article-title":"Murine models of acute myeloid leukaemia","volume":"20","author":"Almosailleakh","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2024051415213821300_bib44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1101\/gad.9.6.650","article-title":"p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene","volume":"9","author":"Matsuoka","year":"1995","journal-title":"Genes Dev"},{"issue":"11","key":"2024051415213821300_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41389-021-00366-3","article-title":"Loss of MBD2 attenuates MLL-AF9-driven leukemogenesis by suppressing the leukemic cell cycle via CDKN1C","volume":"10","author":"Zhou","year":"2021","journal-title":"Oncogene"},{"issue":"42","key":"2024051415213821300_bib46","doi-asserted-by":"crossref","first-page":"26340","DOI":"10.1073\/pnas.2014732117","article-title":"Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23\/KMT2A","volume":"117","author":"Bill","year":"2020","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/9\/2193\/2225060\/blooda_adv-2023-011320-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/9\/2193\/2225060\/blooda_adv-2023-011320-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T15:22:45Z","timestamp":1715700165000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/9\/2193\/515223\/Bahcc1-is-critical-for-the-aberrant-epigenetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011320","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]}}}